GENETICS INSTITUTE, ARMED WITH NEW EPO PATENT, SUES ORTHO
Executive Summary
GENETICS INSTITUTE, ARMED WITH NEW EPO PATENT, SUES ORTHO on June 21 in Wilmington, Del. federal court for infringement caused by the use and sale of Procrit (epoetin alfa). In the complaint, Genetics Institute is seeking damages "arising from Ortho's past and continuing infringement" of newly issued patent 5,322,837, attorney's fees, and "such other, further or different relief as the court deems just and appropriate."